Comparison of therapeutic lipid target achievements among high-risk patients in Oman

Khalid Al-Waili, Ibrahim Al-Zakwani, Tamima Al-Dughaishi, Yajnavalka Baneerje, Hilal Al-Sabti, Khamis Al-Hashmi, Hatem Farhan, Khadija Al Habsi, Ali T. Al-Hinai, Khalid Al-Rasadi*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Abstract

We compared therapeutic lipid target achievements among patients with diabetes or coronary heart disease (CHD) in Oman. A retrospective chart review of 94 patients was conducted at an outpatient clinic in Sultan Qaboos University Hospital, Muscat, Oman. The variables included low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and apolipoprotein B (apo B). The overall mean age of the cohort was 59 ± 12 years, 54% were male, 66% were diabetic, 48% hypertensive, 45% had CHD, 94% were on simvastatin, 4% were on fenofibrate, and 2% were on both simvastatin and fenofibrate. Lipid goal attainments of calculated LDL-C (<2.6 mmol/L), apo B (<0.9 g/L), and non-HDL-C (<3.36 mmol/L) were reached in 52%, 39%, and 53% of the patients, respectively. A significant proportion of high-risk patients treated with lipid-lowering agents reach LDL-C but not the apo B treatment targets, suggesting that the use of apo B target values should also be considered.

Original languageEnglish
Pages (from-to)430-435
Number of pages6
JournalAngiology
Volume65
Issue number5
DOIs
Publication statusPublished - May 2014
Externally publishedYes

Keywords

  • Oman
  • apolipoprotein B
  • coronary heart disease
  • diabetes mellitus
  • low-density lipoprotein cholesterol

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Comparison of therapeutic lipid target achievements among high-risk patients in Oman'. Together they form a unique fingerprint.

Cite this